Live attenuated Rev-independent Nef¯SIV enhances acquisition of heterologous SIVsmE660 in acutely vaccinated rhesus macaques.
Rhesus macaques (RMs) inoculated with live-attenuated Rev-Independent Nef¯ simian immunodeficiency virus (Rev-Ind Nef¯SIV) as adults or neonates controlled viremia to undetectable levels and showed no signs of immunodeficiency over 6-8 years of follow-up. We tested the capacity of this live-attenuat...
Main Authors: | Siddappa N Byrareddy, Mila Ayash-Rashkovsky, Victor G Kramer, Sandra J Lee, Mick Correll, Francis J Novembre, Francois Villinger, Welkin E Johnson, Agneta von Gegerfelt, Barbara K Felber, Ruth M Ruprecht |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3787041?pdf=render |
Similar Items
-
P11-19. Altered mucosal distribution of SIV-specific T cells in Rhesus macaques infected with the live-attenuated Rev-independent SIV
by: Van Rompay K, et al.
Published: (2009-10-01) -
SIVsm Tat, Rev, and Nef1: functional characteristics of r-GV internalization on isotypes, cytokines, and intracellular degradation
by: Stuart Elizabeth S, et al.
Published: (2010-07-01) -
Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge.
by: Hugh C Welles, et al.
Published: (2018-12-01) -
Vaccination against endogenous retrotransposable element consensus sequences does not protect rhesus macaques from SIVsmE660 infection and replication.
by: Neil C Sheppard, et al.
Published: (2014-01-01) -
Prime-boost regimen potency and efficacy with alphavirus replicons (SIV antigen) in non-human primates challenged with low-dose intra-rectal SIVsmE660
by: Banerjee K, et al.
Published: (2012-09-01)